Posts in category Healthcare


Oppenheimer Makes Drastic Price Target Cut for Zynerba Pharmaceuticals Inc Following Epilepsy Drug Setback

Upon releasing negative data for lead drug candidate transdermal CBD (ZYN002) on Monday, Zynerba Pharmaceuticals …

Exclusive Interview with RepliCel Life Sciences President and CEO Lee Buckler

RepliCel Life Sciences Inc. (REPCF) (RP.V) is a biotech company looking not to just treat …

Sabby Capital’s Hal Mintz Flips CytRx Corporation (CYTR), Initiates Mannkind Corporation (MNKD)

Fund manager Hal Mintz of the $1.8 billion Sabby Capital fund has made some intriguing …

Savara Inc (SVRA) Receives FDA Guidance for Molgradex

Savara Inc (NASDAQ:SVRA) announced that it has received guidance from the FDA on the clinical …

Aurinia Pharmaceuticals, Inc. (AUPH) Scores Again With Voclosporin

Last week, on April 20, during the National Kidney Foundation 2017 Spring Clinical Meeting in …

Biotech Beat: Aurinia Pharmaceuticals Inc (AUPH), Pulmatrix Inc (PULM)

Recently, two of the biotech world’s biggest needle movers, Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) and Pulmatrix …

Baird’s 2Q Earnings Preview: Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG)

Analyst Brian Skorney from Baird discussed Gilead Sciences, Inc. (NASDAQ:GILD) and Celgene Corporation (NASDAQ:CELG) ahead of …

Piper Jaffray Cautious On Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Following Guidance Revision

Following Teva’s guidance revision, Piper Jaffray analyst David Amsellem maintained a Neutral rating on Teva …